US Stock MarketDetailed Quotes

CMPX Compass Therapeutics

Watchlist
  • 1.650
  • +0.080+5.10%
Close May 2 16:00 ET
  • 1.650
  • 0.0000.00%
Post 16:02 ET
227.02MMarket Cap-5000P/E (TTM)

About Compass Therapeutics Company

Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. Its platform includes common light chain-focused antibody discovery, human display for antibody tuning, stitchmabs, and highly modular and manufacturable bispecific candidates. The company was founded by Thomas J. Schuetz in 2014 and is headquartered in Boston, MA.

Company Profile

SymbolCMPX
Company NameCompass Therapeutics
Listing DateNov 2, 2021
Issue Price3.50
Founded2014
CEODr. Vered Bisker-Leib, M.B.A.,PhD
MarketNASDAQ
Employees32
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address80 Guest Street,Suite 601
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02135
Phone1-617-500-8099
Websitehttp://www.compasstherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Vered Bisker-Leib, M.B.A.,PhD
  • Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer
  • 4.07M
  • Dr. Carl L. Gordon, C.F.A.,PhD
  • Chairman of the Board
  • 222.63K
  • Dr. Thomas J. Schuetz, M.D.,PhD
  • President, Research and Development and Vice Chairman of the Board
  • 4.87M
  • Dr. Mary Ann Gray,PhD
  • Independent Director
  • 163.42K
  • Richard S. Lindahl
  • Independent Director
  • 147.92K
  • Ellen V. Chiniara, J.D.
  • Independent Director
  • 163.42K
  • Dr. Philip J. Ferneau, J.D.
  • Independent Director
  • 193.02K
  • James P. Boylan, M.B.A.
  • Independent Director
  • 45.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg